Eledon Pharmaceuticals, Inc. (ELDN) › Operating Cash FlowEledon Pharmaceuticals, Inc. (ELDN) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2017: -$14.94M2018: -$11.89M2019: -$13.86M2020: -$15.21M2021: -$28.91M2022: -$28.42M2023: -$39.53M2024: -$47.27M2025: -$62.34M-$62.34M2017Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$62.34M-31.9%2024-$47.27M-19.6%2023-$39.53M-39.1%2022-$28.42M+1.7%2021-$28.91M-90.1%2020-$15.21M-9.8%2019-$13.86M-16.5%2018-$11.89M+20.4%2017-$14.94M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share